NeuroStar® TMS Therapy
FDA-cleared, non-medication depression treatment
Existing Patients For Providers →
(855) 940-4867
Greenbrook's Virginia Regional Medical Director, Dr. William Sauvé, was recently on 98.1 WTVR to discuss mental health care during the COVID-19 crisis.
Greenbrook's Virginia Regional Medical Director, Dr. William Sauvé , was recently on 98.1 WTVR to discuss mental health care during the COVID-19 crisis. Dr. Sauvé began practicing psychiatry in the U.S. Marines and later served as a Division Officer of inpatient psychiatry at the Naval Medical Center of San Diego. Dr. Sauvé started working with Greenbrook in 2014 and has since been providing TMS Therapy throughout our Virginia centers. Dr. Sauvé was interviewed by Jeff Wicker and Rebecca Wilde to discuss the basics of TMS Therapy and various changes to the mental health environment since COVID-19 began.
Dr. Sauvé explains that during a crisis such as the COVID-19 pandemic, many people worry about their basic necessities such as water, food, and safety. But, as Dr. Sauvé explains, mental health is just as much of a necessity as physical health. "Isolation cannot cause mental health illness. People are doing well enough and functioning okay. This is not the same thing as being well ... People are putting up with not feeling well every single day-- no one told them that they shouldn't be feeling this way."
As a mechanism for coping with isolation, Dr. Sauvé recommends continuing to stay connected with your loved ones by utilizing video conferencing services such as WebEx, Zoom, Microsoft Teams, or Google Meet to connect with your friends or co-workers after work. During the interview, Dr. Sauvé was asked how a person can tell when the time is right to see a mental health professional. Dr. Sauvé says that "if you are wondering if it is time to give a mental health professional a call.. that means you should call. The first thing I do is help [a person seeking advice] decide whether or not what is bothering them constitutes something that needs treatment or if I can reassure them they are doing okay."
Dr. Sauvé's stresses that during COVID-19, "good mental health care is not an elective procedure. Hospitals have been suspending elective procedures and only focusing on the essentials. Elective procedures mean things that can wait. Mental health is not that. Any kind of mental health or depression is no exception. That is a serious illness that has the potential to wreck someone's life. Every minute wasted is a minute of life that someone cannot get back."
If you have questions or concerns about your mental health, know that help is available. Call a mental health professional or reach out to us at 855-940-4867 .
Listen to Dr. Sauvé's full interview below:
To see all upcoming Greenbrook TMS provider interviews, click here
Take our short quiz to see if TMS therapy or nasal esketamine could be right for you
Subscribe for mental health, self-care, and TMS therapy and nasal esketamine updates for those affected by treatment-resistant depression or OCD.
Thank you for subscribing to our email list!
Oops, there was an error adding your subscription.
Please try again later.
By providing your email address, you are consenting to receive blog updates from Greenbrook TMS Inc. You may unsubscribe from these alerts at any time by following the “unsubscribe” link at the bottom of email alerts. At Greenbrook TMS Inc. we take the privacy and security of your personal information seriously. To learn more about how we protect your personal information, please refer to our Privacy Policy.
Greenbrook supports an accessible internet. If you have any questions about our accessibility features, please contact us at
(855) 940-4867 or info@greenbrooktms.com.
NeuroStar Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode.
The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive-Compulsive Disorder (OCD).
NeuroStar Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).
Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary.
The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient).
Visit neurostar.com for full safety and prescribing information.
Important Safety Information
What is the most important information I should know about SPRAVATO®?
SPRAVATO® can cause serious side effects, including:
Do not take SPRAVATO® if you:
If you are not sure if you have any of the above conditions, talk to your healthcare provider before taking SPRAVATO®.
Before you take SPRAVATO®, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines that you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Taking SPRAVATO® with certain medicine may cause side effects.
Especially tell your healthcare provider if you take central nervous system (CNS) depressants, psychostimulants, or monoamine oxidase inhibitors (MAOIs) medicine. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine.
How will I take SPRAVATO®?
What should I avoid while taking SPRAVATO®?
Do not drive, operate machinery, or do anything where you need to be completely alert after taking SPRAVATO®. Do not take part in these activities until the next day following a restful sleep. See “What is the most important information I should know about SPRAVATO®?”
What are the possible side effects of SPRAVATO®?
SPRAVATO® may cause serious side effects including:
See “What is the most important information I should know about SPRAVATO®?”
Increased blood pressure. SPRAVATO® can cause a temporary increase in your blood pressure that may last for about 4 hours after taking a dose. Your healthcare provider will check your blood pressure before taking SPRAVATO® and for at least 2 hours after you take SPRAVATO®. Tell your healthcare provider right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures after taking SPRAVATO®.
Problems with thinking clearly. Tell your healthcare provider if you have problems thinking or remembering.
Bladder problems. Tell your healthcare provider if you develop trouble urinating, such as a frequent or urgent need to urinate, pain when urinating, or urinating frequently at night.
The most common side effects of SPRAVATO® include:
If these common side effects occur, they usually happen right after taking SPRAVATO® and go away the same day.
These are not all the possible side effects of SPRAVATO®.
Call your doctor for medical advice about side effects. You may report side effects to Johnson & Johnson at 1-800-526-7736, or to the FDA at 1-800-FDA-1088.
What is SPRAVATO® (esketamine) CIII nasal spray?
SPRAVATO® is a prescription medicine used:
SPRAVATO® is not for use as a medicine to prevent or relieve pain (anesthetic). It is not known if SPRAVATO® is safe or effective as an anesthetic medicine.
It is not known if SPRAVATO® is safe and effective for use in preventing suicide or in reducing suicidal thoughts or actions. SPRAVATO® is not for use in place of hospitalization if your healthcare provider determines that hospitalization is needed, even if improvement is experienced after the first dose of SPRAVATO®.
It is not known if SPRAVATO® is safe and effective in children.
Please see full Prescribing Information, including Boxed WARNINGS, and Medication Guide for SPRAVATO® and discuss any questions you may have with your healthcare provider.
All Rights Reserved | Greenbrook TMS NeuroHealth Centers.